Advancements In Diabetes Care Devices, Rise In Obesity Rate And Unhealthy Lifestyle To Drive The Market Growth

Diabetes mellitus is a disorder that affects blood glucose levels. Diabetes in recent years has become one of the serious non-communicable disease-causing fatalities. According to the World Health Organization (WHO), in 2019, 1.5 million deaths were caused by diabetes. Moreover, the WHO states that diabetes is the ninth leading cause of death.

As we move towards technology and comfort, we are also adopting a sedentary lifestyle with low to no physical activity and unhealthy eating habits leading to obesity, excessive body fat, and diabetes. According to the International Diabetes Federation, 537 million adults were living with diabetes worldwide in 2021. Obesity is becoming increasingly common all around the world. Obesity has virtually tripled globally in the previous decade. As of 2019, about 39% of adults (18 years and older) globally were overweight. Obesity was prevalent among 40.0 percent of adults aged 20 to 39, 44.8 percent of adults aged 40 to 59, and 42.8 percent of persons aged 60 and above in the United States. Similarly, the United Kingdom has the highest obesity rate among European countries, with over one-quarter of adults (28.1%) obese and nearly two-thirds of adults (63.4%) overweight (Source: Global Diabetes Community, U.K.).

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=3438?utm_source=Blog&utm_medium=Social&utm_campaign=Product+&utm_content=11-04-2022

In addition, harmful lifestyle choices such as smoking and eating a poor diet raise the risk of type 2 diabetes. Shift work, particularly night shift work, has also been linked to an increased risk of developing type 2 diabetes. Smoking is a key risk factor for diabetes, with smokers having a greater risk than non-smokers. The quantity of cigarettes smoked per day also determines acquiring diabetes. According to the World Health Organization (WHO), the global prevalence of tobacco smoking was 22.8% in 2020.

Self-management of diabetes is important in patients to reduce mortality risk, prevent long-term complications, and reduce healthcare costs. Diabetes care devices play a critical role in the self-management of diabetes. The glucose monitoring devices (GMD) help keep track of the blood glucose levels, and insulin delivery devices help administrate insulin dosages accordingly. Innovations in these devices make it easy and reliable for diabetic patients to manage diabetes without much effort. Devices like continuous glucose monitoring devices (CGMD) are integrated with insulin pumps equipped with automated algorithms and IQ-based technologies, leading to the measurement of blood glucose levels and administration of insulin in accordance with the glucose levels automatically.

Insulin pumps that can be implanted are still in the works. Implantable insulin pumps that assess blood glucose levels and provide the precise insulin dose required are being developed by research teams worldwide. This insulin pump is surgically implanted and can give a constant basal dosage of insulin and a bolus dose as necessary.

With recent developments in continuous glucose monitoring (CGM) and computer algorithms, closed-loop delivery systems or artificial pancreas (AP) development has gained traction. The AP connects three devices:

• A blood glucose (BG) sensor that transmits data to a computer algorithm
• A control algorithm that analyses the data and calculates the appropriate insulin dose
• An insulin infusion pump that delivers insulin according to the computer's instructions

Hybrid closed-loop systems are gaining popularity because they combine algorithm-driven automatic insulin delivery with manual mealtime medications.

Thus, the advancements in diabetes care devices, rise in obesity rate, unhealthy lifestyle, and the prevalence of diabetes are expected to drive the global diabetes care devices market at a CAGR of 6.7% to reach $31.9 billion in 2028, as per a detailed study by the Meticulous Research^®.

Diabetes Care Devices Market by Type [Diabetes Monitoring (CGM, Test Strips, Self-Monitoring Blood Glucose Meters, Lancets, Haemoglobin A1C Testing Kits)], [Insulin Delivery (Syringes, Pens, Pumps, Jet Injectors)] - Global Forecast to 2028

Key Players

The report includes a competitive landscape based on an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past four years . The key players profiled in the global diabetes care devices market report are Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Abbott Laboratories (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), LifeScan IP Holdings, LLC (U.S.), Medtronic PLC (Ireland), Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), and Sanofi AS (France), Tandem Diabetes Care, Inc. (U.S.), Insulate Corporation (U.S.) and DexCom, Inc. (U.S.).

TOP 10 COMPANIES IN DIABETES CARE DEVICES MARKET

Related Reports:

Digital Diabetes Market by Product (SMBG, CGM, Smart Insulin Pump, Smart Insulin Pens, Software, Apps), End User (Home Care, Hospitals and Clinics), and Geography–Global Forecast to 2025 @ https://www.meticulousresearch.com/product/digital-diabetes-market-4946